Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome

NCT06681012 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

Interventions

DEVICE: Gelsectan®
DRUG: Placebo

Sponsor

Devintec Sagl